In re Astex Pharmaceuticals, Inc. Stockholders Litigation, Consol. C.A. No. 8917 (Del. Ch. 2014)
Our firm, together with Wilson Sonsini Goodrich & Rosati, represented Astex Pharmaceuticals, Inc. and its directors in consolidated stockholder class actions challenging Otsuka Pharmaceutical's approximately $900 million acquisition of Astex. The transaction successfully closed in October 2013, and the stockholder-plaintiffs voluntarily dismissed the consolidated action the following month.